DUSTIN WALTER: Open Payments
NPI 1295295806 · CABOT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 26 payments from 12 companies in 2025. Trend: 2023 $78 · 2024 $254 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $151 |
| Astellas Pharma US Inc | 3 | $50 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| PFIZER INC. | 2 | $39 |
| Boston Scientific Corporation | 1 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| ACADIA Pharmaceuticals Inc | 1 | $24 |
| Tris Pharma Inc | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: MOUNJARO, Veozah, TRELEGY ELLIPTA, PREVNAR 20, WaveWriter Alpha Prime 16, Jornay PM, DAYBUE, Dyanavel XR.
Industry payments across AR — which companies pay providers there.
